Vygon SA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Vygon SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7090
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. The company offers products in various specialties such as paediatrics, neonatology, support for post-operative pain relief, anesthesia, emergency and intensive care units, vascular access, surgery and home care, among others. The company manufactures its products at plants in Europe, and the US. Vygon offers its products to healthcare professionals in hospital and independent practitioners. The company sells its products directly and also through a network of distributors across the Americas, Europe, Asia, the Middle East and Africa. It has partnership with various scientific organizations, institutions and non-profitable organizations. Vygon is headquartered in Ecouen, France.

Vygon SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vygon SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vygon SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vygon SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vygon SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Vygon SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Vygon SA, Medical Equipment, Deal Details 10
Partnerships 10
Almirall Enters into Licensing Agreement with Symatese 10
Interrad Medical Enters into Agreement with Vygon 11
Vygon and OxyNov Enter into Distribution Agreement 12
Curie-Cancer Extends Co-Development Agreement With Vygon 13
Vygon Enters Into Distribution Agreement With Ambu 14
Acquisition 15
Vygon Acquires 20% Stake in OxyNov 15
Vygon Acquires Perouse Medical 16
Vygon Acquires Medwin, Medical Device Company 17
Vygon SA – Key Competitors 18
Vygon SA – Key Employees 19
Vygon SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 23
Corporate Communications 23
Jun 23, 2017: Vygon wins an international Business award for safe-enteral.com 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Vygon SA, Medical Equipment, Key Facts, 2017 2
Vygon SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Vygon SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vygon SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vygon SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vygon SA, Deals By Market, 2012 to YTD 2018 8
Vygon SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Almirall Enters into Licensing Agreement with Symatese 10
Interrad Medical Enters into Agreement with Vygon 11
Vygon and OxyNov Enter into Distribution Agreement 12
Curie-Cancer Extends Co-Development Agreement With Vygon 13
Vygon Enters Into Distribution Agreement With Ambu 14
Vygon Acquires 20% Stake in OxyNov 15
Vygon Acquires Perouse Medical 16
Vygon Acquires Medwin, Medical Device Company 17
Vygon SA, Key Competitors 18
Vygon SA, Key Employees 19
Vygon SA, Other Locations 20
Vygon SA, Subsidiaries 20

List of Figures
Vygon SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Vygon SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Vygon SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Vygon SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Vygon SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vygon SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Vygon SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vygon SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Vygon SA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NTT DOCOMO, Inc.:企業の戦略・SWOT・財務情報
    NTT DOCOMO, Inc. - Strategy, SWOT and Corporate Finance Report Summary NTT DOCOMO, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nordex SE (NDX1):電力:M&Aディール及び事業提携情報
    Summary Nordex SE (Nordex) is an integrated supplier of onshore wind turbine systems. It develops, produces, services and markets wind power systems. The company develops and produces complete systems, including the control software and main core components, and offers related services. Nordex serve …
  • Chrono Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Chrono Therapeutics Inc (CTI) is a personalized medicine manufacturer that provides programmable passive transdermal drug delivery products. The company provides smartstop, a programmable smoking cessation therapy that helps people to quit smoking and improve cessation outcomes. Its wearable …
  • Janssen Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Janssen Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Janssen Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • PT Adaro Energy Tbk:企業の戦略・SWOT・財務情報
    PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Starpharma Holdings Ltd (SPL):企業の財務・戦略的SWOT分析
    Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Oneness Biotech Co Ltd (4743):製薬・医療:M&Aディール及び事業提携情報
    Summary Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company that conducts research and development of drugs. The company provides products such as anti acne products. Its technologies comprise GAP cultivation platform, medicinal material identification, and separation and purific …
  • Etex Group Sa
    Etex Group Sa - Strategy, SWOT and Corporate Finance Report Summary Etex Group Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • OP Financial Group:企業の戦略・SWOT・財務分析
    OP Financial Group - Strategy, SWOT and Corporate Finance Report Summary OP Financial Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • Maquet Holding BV & Co KG:医療機器:M&Aディール及び事業提携情報
    Summary Maquet Holding BV & Co KG (Maquet), a subsidiary of Getinge AB, designs, develops and sells medical systems. The company’s major products include anesthesia delivery systems, surgical assist systems, fixed equipment, mobile equipment, operation room lights and ceiling supply units, vascular …
  • Insurance Australia Group Limited:企業のM&A・事業提携・投資動向
    Insurance Australia Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Insurance Australia Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Biocept Inc (BIOC):企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Dirui Industrial Co Ltd (300396):企業の財務・戦略的SWOT分析
    Summary Dirui Industrial Co Ltd (Dirui) is a provider of total laboratory solutions. The company designs, develops, manufactures, and markets diagnostic medical equipment, reagents, and clinical diagnostic reagents. Its products include chemistry analyzer, urine analyzer, hematology analyzer, fecal …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Eden Innovations (EDE):石油・ガス:M&Aディール及び事業提携情報
    Summary Eden Innovations, formerly Eden Energy Ltd, is a clean energy company that offers carbon nanotube and carbon fibre production, nanomaterial concrete admixtures, hydrogen production, and storage and transport fuel system. The company manufactures and distributes fuel systems, pumps, fuel tank …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • Helomics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Compal Electronics Inc (2324):企業の財務・戦略的SWOT分析
    Summary Compal Electronics Inc (Compal) is a manufacturer of notebook based personal computers, liquid crystal display (LCD) products and smart devices. The company offers products which include display, communication, ODM and OEM, digital media, smart devices and automotive electronics. It also off …
  • Catholic United Financial:企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆